Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
China
· Delayed Price · Currency is CNY 3.810
-0.040 (-1.04%)
May 21, 2025, 3:00 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Wholesale Medical | 6.15B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Wholesale Medical Growth | 3.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nutritional Supplements | 2.87B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nutritional Supplements Growth | 40.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Wholesale Commercial | 2.50B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Wholesale Commercial Growth | 17.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Retail | 1.60B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Retail Growth | 10.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-virus and Anti-infection | 1.02B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-virus and Anti-infection Growth | 14.67% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cold Medicine | 536.39M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cold Medicine Growth | -8.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Digestive System | 256.35M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Digestive System Growth | -14.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular | 221.54M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular Growth | -23.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-tumor | 214.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 95.03M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 14817.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Industrial - Others | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Industrial - Others Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| China | 14.39B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 6.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas | 1.07B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Growth | 202.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|